🔗 Share this article

The prestigious award in medical science was awarded for transformative discoveries that illuminate how the body's defense network attacks dangerous pathogens while protecting the healthy tissues.

A trio of esteemed scientists—Japan's Shimon Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—received this honor.

The research identified unique "sentinels" within the defense system that remove malfunctioning defense cells that could harming the body.

The discoveries are now enabling innovative treatments for immune disorders and malignancies.

The laureates will share a monetary award valued at 11m SEK.

Decisive Discoveries

"Their research has been decisive for comprehending how the immune system operates and why we do not all develop severe self-attack conditions," commented the head of the award panel.

This trio's research explain a core mystery: How does the defense system protect us from countless infections while keeping our own tissues intact?

The body's protection system employs white blood cells that search for signs of disease, even viruses and bacteria it has never encountered.

Such cells employ sensors—called recognition units—that are generated randomly in a vast number of variations.

This provides the defense network the capacity to fight a wide array of threats, but the unpredictability of the process inevitably produces immune cells that may attack the body.

Security Guards of the Body

Researchers previously understood that some of these harmful defense cells were eliminated in the thymus—the site where immune cells mature.

This year's award recognizes the identification of T-reg cells—described as the body's "peacekeepers"—which travel through the system to disarm other immune cells that assault the body's own tissues.

We know that this mechanism fails in autoimmune diseases such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

A prize committee added, "The findings have laid the foundation for a novel area of investigation and spurred the development of innovative treatments, for instance for cancer and autoimmune diseases."

In cancer, regulatory T-cells prevent the body from attacking the tumor, so research are focused on lowering their quantity.

For self-attack disorders, trials are testing boosting regulatory T-cells so the organism is no longer under attack. A similar method could also be effective in minimizing the risks of transplanted organ failure.

Innovative Experiments

Professor Sakaguchi, from Osaka University, conducted experiments on mice that had their thymus extracted, leading to self-attack conditions.

He demonstrated that introducing defense cells from healthy mice could prevent the illness—implying there was a mechanism for blocking defenders from harming the body.

Dr. Brunkow, from the Institute for Systems Biology in Seattle, and Fred Ramsdell, currently at Sonoma Biotherapeutics in a California city, were investigating an genetic autoimmune disease in mice and people that led to the discovery of a gene vital for how regulatory T-cells function.

"Their groundbreaking research has revealed how the immune system is kept in check by regulatory T cells, stopping it from mistakenly attacking the healthy cells," commented a prominent biological science expert.

"This work is a remarkable illustration of how fundamental biological study can have far-reaching implications for human health."